Role of topiramate in adults with intractable epilepsy, mental retardation, and developmental disabilities

Seizure

Volumn 11, Issue 1, 2002, Pages 47-50

  Singh, Baldev K ^a   White Scott, Sheryl ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Developmental disabilities; Epilepsy; Mental retardation; Seizures; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID;

ADULT; ALERTNESS; ALLERGY; ANAPHYLACTIC SHOCK; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; DISORIENTATION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FISH; FOLLOW UP; HUMAN; INTRACTABLE EPILEPSY; MALE; MENTAL DEFICIENCY; PNEUMONIA; PRIORITY JOURNAL; SEIZURE;

EID: 0036185076     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1053/seiz.2001.0571     Document Type: Article

References (12)

1. Antiepileptic drug status in adult outpatients with mental retardation
2. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures
3. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400- and 600-mg daily dosages
4. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages
5. Double-blind, placebo-controlled trial of topiramate in patients with refractory epilepsy
6. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy
7. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children
8. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures
9. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome
10. Safety of topiramate: Adverse events and relationships to dosing
11. Practical aspects of the use of topiramate in patients with epilepsy
12. Proposal for revised clinical and electroencephalographic classification of epileptic seizures